Tramadol Hydrochloride Tablet, Extended Release
Product Images NDC 68180-698

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Tramadol Hydrochloride (NDC 68180-698). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-1 (251da4a2 F5b6 40c0 Ae16 C4dbc8212cc3 01)

Chemical structure of Tramadol Hydrochloride depicted in a molecular diagram with labeled functional groups and bonds, illustrating its chemical composition and hydrochloride salt form.*

FDA Label Image

Image-2 (251da4a2 F5b6 40c0 Ae16 C4dbc8212cc3 02)

A line graph comparing plasma Tramadol concentration (ng/mL) over 24 hours after oral administration of Tramadol Hydrochloride Extended-Release Tablets 200 mg once daily versus Tramadol Hydrochloride Tablets 50 mg every 6 hours. The x-axis represents time in hours, and the y-axis represents tramadol concentration.*

FDA Label Image

Image-3 (251da4a2 F5b6 40c0 Ae16 C4dbc8212cc3 03)

A line graph comparing plasma concentration of M1 metabolite over 24 hours for Tramadol Hydrochloride Extended-Release Tablets 200 mg once daily versus Tramadol Hydrochloride Tablets 50 mg every 6 hours. The x-axis represents time in hours, and the y-axis shows M1 concentration in ng/mL. Two curves display fluctuation in concentration for each formulation.*

FDA Label Image

Image-4 (251da4a2 F5b6 40c0 Ae16 C4dbc8212cc3 04)

A line graph titled 'Tramadol Hydrochloride Extended-Release Tablets Study 023 WOMAC Pain Responder Analysis' depicting percent of patients achieving response versus response threshold (percent improvement from baseline). It compares five groups: Tramadol Hydrochloride Extended-Release Tablets at 100 mg, 200 mg, 300 mg, and 400 mg doses, and a placebo. Each dose group is represented by distinct markers, showing a decline in percent responders as the response threshold increases.*

FDA Label Image

Image-5 (251da4a2 F5b6 40c0 Ae16 C4dbc8212cc3 05)

A line graph illustrating the arthritis pain intensity VAS responder analysis from Study 015, showing the percentage of patients achieving various levels of response threshold for Tramadol Hydrochloride Extended-Release Tablets compared to placebo. The x-axis represents the response threshold as percent improvement from baseline, and the y-axis shows the percent of patients achieving the response. The graph indicates higher patient response percentages for Tramadol Hydrochloride Extended-Release Tablets across all thresholds compared to placebo.*

FDA Label Image

Image (86731d11 21c5 43e2 A5df B96262c9ba5c 408 1)

TRAMADOL HYDROCHLORIDE extended release tablet carton, showing the product name and dosage strengths 100 mg, 200 mg, and 300 mg. The packaging includes a graphic design with black and gray geometric shapes on a white background. Labeler is Lupin Pharmaceuticals, Inc.*

FDA Label Image

Image (86731d11 21c5 43e2 A5df B96262c9ba5c 393 1)

Packaging label for TRAMADOL HYDROCHLORIDE 200 mg extended-release tablets by Lupin Pharmaceuticals, Inc. The image shows a white rectangular blister pack containing 10 oval tablets arranged in two rows of five. The tablets are white with no visible scoring or imprint. The blister is sealed with a foil backing.*

FDA Label Image

Image (251da4a2 F5b6 40c0 Ae16 C4dbc8212cc3 06)

Label for Tramadol Hydrochloride Extended-release Tablets USP 100 mg by Lupin Pharmaceuticals, Inc. The label states it is Rx only, contains 30 tablets per package, and is for once daily oral use. Storage and prescription information, a barcode, and a QR code for medication guide access are also visible.*

FDA Label Image

Image-7 (251da4a2 F5b6 40c0 Ae16 C4dbc8212cc3 07)

Label for Tramadol Hydrochloride Extended-release Tablets USP 200 mg, oral tablets. The label indicates a package of 30 tablets. It includes dosing information, storage instructions, and manufacturer details, Lupin Pharmaceuticals, Inc., Naples, FL, USA, with Lupin Limited in India also mentioned. The NDC number 68180-698-06 is visible along with a barcode and a QR code linking to the medication guide.*

FDA Label Image

Image-8 (251da4a2 F5b6 40c0 Ae16 C4dbc8212cc3 08)

Label for Tramadol Hydrochloride Extended-Release Tablets USP 300 mg by Lupin Pharmaceuticals, Inc. The oral tablet is shown as a 30-count prescription package. Label includes NDC 68180-699-06, dosage form, strength, and storage instructions. A QR code directs to the medication guide.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.